Current Issue
Subscribe
More new drugs are in the pipeline now than in past decades
Pseudotumors are rare in countries with access to hemophilia treatment, but it’s important for those at risk to know about this potentially life-threatening complication.
The Food and Drug Administration approved Corifact, the first factor treatment for factor XIII deficiency, on February 17, 2011.
1-2%
of people in the US have von Willebrand disease, the most common bleeding disorder.